AA

Asim Ahmed

Active Director Director DIN 09087296
DIN 09087296 First appointment Mar 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Asim Ahmed

Data last updated:

Asim Ahmed is a Director at Cogentech Sciences Private Limited (since 2021). The company operates in Chemicals. Cogentech Sciences Private Limited reported revenue of ₹2.6 Lakh (FY 2024).

DIN 09087296
Primary Designation Director
Industry Chemicals
First Appointment 02 Mar 2021
Oldest Company Age 5 yrs
Largest company Cogentech Sciences Private Limited · ₹2.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cogentech Sciences Private Limited U24230UP2021PTC142656
Director02 Mar 20212021₹2.6 Lakh (FY 2024)Active

Board colleagues of Asim Ahmed

Directorship timeline

Open interactive timeline →
Cogentech Sciences Private Limited
Premium access

Shareholding and investment profile for Asim Ahmed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asim Ahmed

Asim Ahmed currently holds 1 directorship: Cogentech Sciences Private Limited (Director, since 02 Mar 2021, revenue ₹2.6 Lakh (FY 2024)).

Asim Ahmed was first appointed on 02 Mar 2021 as Director at Cogentech Sciences Private Limited.

The current boards of Asim Ahmed's companies include Farheen Samar (Cogentech Sciences Private Limited), Mohit Sharma (Cogentech Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available